The efficacy of BCG-induced tumor immunity in guinea pigs with regional and systemic malignancy
- 1 June 1976
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 1 (3), 171-177
- https://doi.org/10.1007/bf00205462
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Characterization of in vitro reactivity by BCG-treated guinea pigs to syngeneic line-10 hepatocarcinomaCancer Immunology, Immunotherapy, 1976
- Histopathology of Tumor Regression After Intralesional Injection of Mycobacferium bovis . IV. Development of Immunity to Tumor Cells and BCG 2JNCI Journal of the National Cancer Institute, 1973
- Immunotherapy in Patients with MelanomaAnnals of Surgery, 1973
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovisScience, 1971
- Immunological Factors in Human Sarcomas and MelanomasAnnals of Surgery, 1970